Amedeo Smart

Free Medical Literature Service


 

Amedeo

Peptic Ulcer

  Free Subscription

Articles published in
Am J Gastroenterol
    September 2021
  1. BHATTACHARYA S, Blau JE, Cochran C, Auh S, et al
    Validity of Secretin Stimulation Testing on Proton Pump Inhibitor Therapy for Diagnosis of Zollinger-Ellison Syndrome.
    Am J Gastroenterol. 2021 Sep 13. pii: 00000434-990000000-00098.
    >> Share

    August 2021
  2. CHENG YY, Tsai MC, Wei JC
    Response to "Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy".
    Am J Gastroenterol. 2021 Aug 27. pii: 00000434-990000000-00086.
    >> Share

  3. LV XH, Wang ZJ, Yang JL
    Proton Pump Inhibitors and COVID-19: Confusing Status Quo.
    Am J Gastroenterol. 2021 Aug 16. pii: 00000434-990000000-00070.
    >> Share

    July 2021
  4. HE Q, Xia B, Meng W, Fan D, et al
    No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million Participants.
    Am J Gastroenterol. 2021 Jul 27. pii: 00000434-990000000-00057.
    >> Share

  5. SINGH AD, Zhang X, Anwer F, Bhatt A, et al
    Isolated Gastric Amyloid Light Chain Amyloidosis Causing Upper Gastrointestinal Bleeding.
    Am J Gastroenterol. 2021 Jul 23. pii: 00000434-990000000-00056.
    >> Share

  6. RIBOLSI M, Luca Guarino MP, Balestrieri P, Altomare A, et al
    The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough.
    Am J Gastroenterol. 2021 Jul 21. pii: 00000434-990000000-00054.
    >> Share

  7. LABENZ C, Labenz J
    Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.
    >> Share

  8. ZHANG B, Hu Y, Shi X, Li W, et al
    Integrative Effects and Vagal Mechanisms of Transcutaneous Electrical Acustimulation on Gastroesophageal Motility in Patients With Gastroesophageal Reflux Disease.
    Am J Gastroenterol. 2021;116:1495-1505.
    >> Share

    June 2021
  9. SHIN GY, Park JM, Hong J, Cho YK, et al
    Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Am J Gastroenterol. 2021;116:1211-1219.
    >> Share

    May 2021
  10. LIU JJ, Sloan ME, Owings AH, Figgins E, et al
    Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy.
    Am J Gastroenterol. 2021 May 27. pii: 00000434-900000000-98767.
    >> Share

  11. WATANABE K, Shimodaira Y, Takahashi S, Fukuda S, et al
    Potent Acid Suppression With Vonoprazan vs Proton Pump Inhibitors Does Not Have Higher Association With Clostridioides difficile Infection.
    Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98781.
    >> Share

  12. BOTTERI E, Gallus S, Lugo A
    Response to Hoffmeister et al.
    Am J Gastroenterol. 2021;116:1093-1094.
    >> Share

  13. TSAY CJ, Protiva P
    Chronic Mesenteric Ischemia With Peristaltic Blanching.
    Am J Gastroenterol. 2021;116:870.
    >> Share

    April 2021
  14. NYSSEN OP, Perez-Aisa A, Tepes B, Castro-Fernandez M, et al
    Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg).
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98822.
    >> Share

    February 2021
  15. BISSELING TM, van Laarhoven A, Huijbers A, Brink M, et al
    Coronavirus Disease-19 Presenting as Esophageal Ulceration.
    Am J Gastroenterol. 2021;116:421-424.
    >> Share

    January 2021
  16. SUGIYAMA T
    Long-Term Safety of Proton Pump Inhibitors: Bone Fracture Risk as an Example.
    Am J Gastroenterol. 2021 Jan 22. pii: 00000434-900000000-98932.
    >> Share

    December 2020
  17. LISA Y, Robert C
    P051 Proton Pump Inhibitors are Associated with Less Severe Periodontal Disease: Considerations for IBD Patients.
    Am J Gastroenterol. 2020;115.
    >> Share

    November 2020
  18. ALMARIO CV, Chey WD, Spiegel BMR
    Response to Hajifathalian and Katz Regarding Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
    Am J Gastroenterol. 2020;115:1922-1923.
    >> Share

  19. BOUSHEY H, Gonda I
    Comment on Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
    Am J Gastroenterol. 2020;115:1921.
    >> Share

  20. TARLOW B, Gubatan J, Khan MA, Cholankeril G, et al
    Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?
    Am J Gastroenterol. 2020;115:1920-1921.
    >> Share

  21. HADI YB, Naqvi SF, Kupec JT
    Risk of COVID-19 in Patients Taking Proton Pump Inhibitors.
    Am J Gastroenterol. 2020;115:1919-1920.
    >> Share

  22. HAJIFATHALIAN K, Katz PO
    Regarding "Increased Risk of COVID-19 in Patients Taking Proton Pump Inhibitors".
    Am J Gastroenterol. 2020;115:1918-1919.
    >> Share

  23. ABY ES, Rodin H, Debes JD
    Proton Pump Inhibitors and Mortality in Individuals With COVID-19.
    Am J Gastroenterol. 2020;115:1918.
    >> Share

  24. KOTHARI TH, Enslin S, Cheong J, Kaul V, et al
    Treatment of Bouveret Syndrome Using an Ultrathin Gastroscope: Making the Best out of a Tight Situation!
    Am J Gastroenterol. 2020;115:1748.
    >> Share

    October 2020
  25. GUO H, Lam AY, Shaheen AA, Forbes N, et al
    Urban-Rural Disparities and Temporal Trends in Peptic Ulcer Disease Epidemiology, Treatment, and Outcomes in the United States.
    Am J Gastroenterol. 2020 Oct 22. doi: 10.14309/ajg.0000000000000997.
    >> Share

  26. BOUSHEY H, Gonda I
    Comment on Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001014.
    >> Share

  27. HAJIFATHALIAN K, Katz PO
    Regarding "Increased Risk of COVID-19" in Patients Taking Proton Pump Inhibitors.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000920.
    >> Share

  28. HADI YB, Naqvi SF, Kupec JT
    Risk of COVID-19 in Patients Taking Proton Pump Inhibitors.
    Am J Gastroenterol. 2020 Oct 1. doi: 10.14309/ajg.0000000000000949.
    >> Share

  29. MARTIN TA, Wan DW, Hajifathalian K, Tewani S, et al
    Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control Study.
    Am J Gastroenterol. 2020;115:1609-1616.
    >> Share

    September 2020
  30. ABY ES, Rodin H, Debes JD
    Proton Pump Inhibitors and Mortality in Individuals With COVID-19.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000992.
    >> Share

  31. HALLAND M, Bharucha AE, Crowell MD, Ravi K, et al
    Effects of Diaphragmatic Breathing on the Pathophysiology and Treatment of Upright Gastroesophageal Reflux: A Randomized Controlled Trial.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000913.
    >> Share

  32. TARLOW B, Gubatan J, Khan MA, Cholankeril G, et al
    Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?
    Am J Gastroenterol. 2020 Sep 11. doi: 10.14309/ajg.0000000000000933.
    >> Share

    August 2020
  33. ALMARIO CV, Chey WD, Spiegel BMR
    Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
    Am J Gastroenterol. 2020 Aug 25. doi: 10.14309/ajg.0000000000000798.
    >> Share

  34. SKOLE KS, Mahpour NY
    There Are Several Reasons to Not Treat H. pylori....
    Am J Gastroenterol. 2020;115:1301.
    >> Share

    July 2020
  35. KAMAL AN, Clarke JO, Oors JM, Smout AJ, et al
    The Role of Symptom Association Analysis in Gastroesophageal Reflux Testing.
    Am J Gastroenterol. 2020 Jul 29. doi: 10.14309/ajg.0000000000000754.
    >> Share

  36. LI X, Huang S, Lu J, Lai R, et al
    Upper Gastrointestinal Bleeding Caused by SARS-CoV-2 Infection.
    Am J Gastroenterol. 2020 Jul 20. doi: 10.14309/ajg.0000000000000757.
    >> Share

  37. SONNENBERG A, Turner KO, Genta RM
    Correction: Low Prevalence of Helicobacter pylori-Positive Peptic Ulcers in Private Outpatient Endoscopy Centers in the United States.
    Am J Gastroenterol. 2020;115:1145.
    >> Share

  38. MELAZZINI F, Lenti MV, Mauro A, De Grazia F, et al
    Peptic Ulcer Disease as a Common Cause of Bleeding in Patients with Coronavirus Disease 2019.
    Am J Gastroenterol. 2020;115:1139-1140.
    >> Share

    May 2020
  39. GAJENDRAN M, Perisetti A, Goyal H
    Timing of Feeding After Endoscopic Intervention in Peptic Ulcer Disease.
    Am J Gastroenterol. 2020 May 27. doi: 10.14309/ajg.0000000000000698.
    >> Share

  40. GEERAERTS A, Van Houtte B, Clevers E, Geysen H, et al
    Gastroesophageal Reflux Disease-Functional Dyspepsia Overlap: Do Birds of a Feather Flock Together?
    Am J Gastroenterol. 2020 May 25. doi: 10.14309/ajg.0000000000000619.
    >> Share

  41. MELAZZINI F, Lenti MV, Mauro A, De Grazia F, et al
    Peptic Ulcer Disease as a Common Cause of Bleeding in Patients with Coronavirus Disease 2019.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000710.
    >> Share

  42. KUMAR S, Metz DC, Kaplan DE, Goldberg DS, et al
    Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection.
    Am J Gastroenterol. 2020;115:716-722.
    >> Share

  43. SHEPHERD K, Ockelford J, Ganasan V, Holloway R, et al
    Temporal Relationship Between Night-Time Gastroesophageal Reflux Events and Arousals From Sleep.
    Am J Gastroenterol. 2020;115:697-705.
    >> Share

  44. LONGSTRETH GF
    Internists' Misconceptions About PPIs: Increasing Knowledge and Implementing Guidelines.
    Am J Gastroenterol. 2020;115:681-682.
    >> Share

  45. BAZERBACHI F, Chandrasekhara V
    Ulcere Perfore-Bouche.
    Am J Gastroenterol. 2020;115:649.
    >> Share

    March 2020
  46. LEE JK, Merchant SA, Schneider JL, Jensen CD, et al
    Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
    Am J Gastroenterol. 2020 Mar 20. doi: 10.14309/ajg.0000000000000591.
    >> Share

  47. GONG EJ, Lee SJ, Jun BG, Seo HI, et al
    Optimal Timing of Feeding After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding: A Randomized, Noninferiority Trial (CRIS KCT0001019).
    Am J Gastroenterol. 2020 Mar 20. doi: 10.14309/ajg.0000000000000584.
    >> Share

  48. SONNENBERG A, Turner KO, Genta RM
    Correction: Low Prevalence of Helicobacter pylori-Positive Peptic Ulcers in Private Outpatient Endoscopy Centers in the United States.
    Am J Gastroenterol. 2020 Mar 5. doi: 10.14309/ajg.0000000000000592.
    >> Share

  49. LAI SW, Liao KF
    Association Between Proton Pump Inhibitors Use and Dementia Risk.
    Am J Gastroenterol. 2020 Mar 4. doi: 10.14309/ajg.0000000000000576.
    >> Share

    February 2020
  50. KURLANDER JE, Rubenstein JH, Richardson CR, Krein SL, et al
    Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.
    Am J Gastroenterol. 2020 Feb 24. doi: 10.14309/ajg.0000000000000558.
    >> Share

  51. BAGGOTT BB, Vogt D, Harris KB, Vargo JJ, et al
    Pancreatic Rest Tissue: An Unusual Cause of Nonhealing Gastric Ulcer.
    Am J Gastroenterol. 2020 Feb 5. doi: 10.14309/ajg.0000000000000524.
    >> Share

    January 2020
  52. SONNENBERG A, Turner KO, Genta RM
    Low Prevalence of Helicobacter pylori-Positive Peptic Ulcers in Private Outpatient Endoscopy Centers in the United States.
    Am J Gastroenterol. 2020 Jan 15. doi: 10.14309/ajg.0000000000000517.
    >> Share

  53. KHAN MA, Yuan Y, Iqbal U, Kamal S, et al
    No Association Linking Short-Term Proton Pump Inhibitor Use to Dementia: Systematic Review and Meta-analysis of Observational Studies.
    Am J Gastroenterol. 2020 Jan 2. doi: 10.14309/ajg.0000000000000500.
    >> Share

    October 2019
  54. CHEY WD
    Helicobacter pylori: When We Should Treat....
    Am J Gastroenterol. 2019 Oct 25. doi: 10.14309/ajg.0000000000000425.
    >> Share

    August 2019
  55. SUGIYAMA T
    Response to Lai "Proton Pump Inhibitors and Fracture Risk".
    Am J Gastroenterol. 2019 Aug 28. doi: 10.14309/ajg.0000000000000390.
    >> Share

    July 2019
  56. LAI SW
    Proton Pump Inhibitors and Fracture Risk.
    Am J Gastroenterol. 2019 Jul 30. doi: 10.14309/ajg.0000000000000342.
    >> Share

    June 2019
  57. NAKAGAWA K, Sawada A, Hoshikawa Y, Nikaki K, et al
    Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring.
    Am J Gastroenterol. 2019 Jun 26. doi: 10.14309/ajg.0000000000000295.
    >> Share

    May 2019
  58. WIENS EJ, Mylnikov A
    Hypoxic Respiratory Failure Complicating Esophagogastroduodenoscopy.
    Am J Gastroenterol. 2019;114:706.
    >> Share

    April 2019
  59. BOLTIN D, Levi Z, Gingold-Belfer R, Gabay H, et al
    Impact of Previous Exposure to Macrolide Antibiotics on Helicobacter pylori Infection Treatment Outcomes.
    Am J Gastroenterol. 2019 Apr 25. doi: 10.14309/ajg.0000000000000223.
    >> Share

  60. YANG J, Zhang Y, Fan L, Zhu YJ, et al
    Correction: Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
    Am J Gastroenterol. 2019 Apr 3. doi: 10.14309/ajg.0000000000000230.
    >> Share

    March 2019
  61. HUNGIN APS, Molloy-Bland M, Scarpignato C
    Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD.
    Am J Gastroenterol. 2019;114:414-421.
    >> Share

    February 2019
  62. YANG J, Zhang Y, Fan L, Zhu YJ, et al
    Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
    Am J Gastroenterol. 2019 Feb 25. doi: 10.14309/ajg.0000000000000132.
    >> Share

    January 2019
  63. KURLANDER JE, Kennedy JK, Rubenstein JH, Richardson CR, et al
    Patients' Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation: A National Survey.
    Am J Gastroenterol. 2019 Jan 23. doi: 10.14309/ajg.0000000000000061.
    >> Share

  64. SUGIYAMA T
    Proton Pump Inhibitor Use and Fracture Risk: An Update of Drug Safety Communication Needed?
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000053.
    >> Share

    October 2018
  65. WANG Z, Thrift AP
    Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence: Reply From Authors.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0356.
    >> Share

    September 2018
  66. KOUNTOURAS J, Doulberis M, Polyzos SA, Zeglinas C, et al
    Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0214.
    >> Share

    August 2018
  67. CHEN MJ, Chen CC, Chen YN, Chen CC, et al
    Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection.
    Am J Gastroenterol. 2018 Aug 31. pii: 10.1038/s41395-018-0217.
    >> Share

    June 2018
  68. KINOSHITA Y, Ishimura N, Ishihara S
    Management of GERD: Are Potassium-Competitive Acid Blockers Superior to Proton Pump Inhibitors?
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0183.
    >> Share

  69. QAYED E, Samo S
    The Effect of Hematemesis Type on Outcomes in Upper Gastrointestinal Bleeding.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0155.
    >> Share

  70. TALLEY NJ, Walker MM
    The Rise and Rise of Eosinophilic Gut Diseases Including Eosinophilic Esophagitis Is Probably Not Explained by the Disappearance of Helicobacter pylori, so Who or What's to Blame?
    Am J Gastroenterol. 2018 Jun 18. pii: 10.1038/s41395-018-0125.
    >> Share

  71. SUDO G, Tanuma T, Nakase H
    Gastric Ulcer Bleeding Due to Left Gastric Artery Pseudoaneurysm.
    Am J Gastroenterol. 2018 Jun 14. pii: 10.1038/s41395-018-0126.
    >> Share

  72. CHEY WD, Leontiadis GI, Howden CW, Moss SF, et al
    Correction: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
    Am J Gastroenterol. 2018 Jun 12. pii: 10.1038/s41395-018-0132.
    >> Share

  73. PELLICANO R
    Oral Capsaicin Test and Functional Dyspepsia: Any Consideration for Helicobacter pylori Infection and Concomitant Medications?
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0153.
    >> Share

  74. WANG Z, Shaheen NJ, Whiteman DC, Anderson LA, et al
    Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0070.
    >> Share

  75. BAJAJ JS, Acharya C, Fagan A, White MB, et al
    Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
    Am J Gastroenterol. 2018 Jun 6. pii: 10.1038/s41395-018-0085.
    >> Share

  76. ALEXEEVA O, Keswani RN, Pandolfino JE, Liebovitz D, et al
    Electronic Clinical Decision Support Tools for Obesity and Gastroesophageal Reflux Disease: The Provider's Perspective.
    Am J Gastroenterol. 2018 Jun 1. pii: 10.1038/s41395-018-0092.
    >> Share

    April 2018
  77. YADLAPATI R, Vaezi MF, Vela MF, Spechler SJ, et al
    Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel.
    Am J Gastroenterol. 2018 Apr 24. pii: 10.1038/s41395-018-0045.
    >> Share

    March 2018
  78. MOLINA-INFANTE J, Gutierrez-Junquera C, Savarino E, Penagini R, et al
    Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study.
    Am J Gastroenterol. 2018 Mar 15. pii: 10.1038/s41395-018-0035.
    >> Share

  79. CHAHAL P
    Continuing Medical Education Questions: March 2018: Severity And Outcomes Of Upper Gastrointestinal Bleeding With Bloody Vs. Coffee-Grounds Hematemesis.
    Am J Gastroenterol. 2018;113:367.
    >> Share

    February 2018
  80. GLASINOVIC E, Wynter E, Arguero J, Ooi J, et al
    Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux.
    Am J Gastroenterol. 2018 Feb 20. pii: ajg201815. doi: 10.1038/ajg.2018.
    >> Share

    January 2018
  81. LAINE L, Laursen SB, Zakko L, Dalton HR, et al
    Severity and Outcomes of Upper Gastrointestinal Bleeding With Bloody Vs. Coffee-Grounds Hematemesis.
    Am J Gastroenterol. 2018 Jan 30. pii: ajg20185. doi: 10.1038/ajg.2018.
    >> Share

  82. HSU PI, Tsai FW, Kao SS, Kao JY, et al
    Time to Make a Change in the Cutoff Value of Clarithromycin Resistance in the Treatment of Helicobacter pylori Infection.
    Am J Gastroenterol. 2018;113:142-143.
    >> Share

    December 2017
  83. MOAYYEDI P, Lewis MA
    Proton Pump Inhibitors and Dementia: Deciphering the Data.
    Am J Gastroenterol. 2017;112:1809-1811.
    >> Share

  84. ZULLO A, De Francesco V, Vaira D
    Is Double-Dose Esomeprazole With Bismuth Really Safe?
    Am J Gastroenterol. 2017;112:1894-1895.
    >> Share

    October 2017
  85. MOLINA-INFANTE J, Lucendo AJ
    Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: A Paradigm Shift.
    Am J Gastroenterol. 2017 Oct 31. doi: 10.1038/ajg.2017.
    >> Share

  86. YADLAPATI R, Pandolfino JE, Alexeeva O, Gregory DL, et al
    The Reflux Improvement and Monitoring (TRIM) Program Is Associated With Symptom Improvement and Weight Reduction for Patients With Obesity and Gastroesophageal Reflux Disease.
    Am J Gastroenterol. 2017 Oct 10. doi: 10.1038/ajg.2017.
    >> Share

  87. DAI C, Cao Q, Jiang M
    Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population.
    Am J Gastroenterol. 2017;112:1620-1621.
    >> Share

    July 2017
  88. HSU PI, Tsai FW, Kao SS, Hsu WH, et al
    Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Tria
    Am J Gastroenterol. 2017 Jul 18. doi: 10.1038/ajg.2017.
    >> Share

  89. TAIPALE H, Tolppanen AM, Tiihonen M, Tanskanen A, et al
    No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease.
    Am J Gastroenterol. 2017 Jul 11. doi: 10.1038/ajg.2017.
    >> Share

  90. GEORGOPOULOS SD, Xirouchakis E
    Which Regimens Should Be Used and Which Rejected for the Treatment of Helicobacter pylori?
    Am J Gastroenterol. 2017;112:1168-1169.
    >> Share

    May 2017
  91. AGREUS L, Svardsudd K, Talley NJ, Jones MP, et al
    Corrigendum: Natural History of Gastroesophageal Reflux Disease and Functional Abdominal Disorders: A Population-Based Study.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    >> Share

  92. GOYAL H, Katner H
    Proton Pump Inhibitors and Clostridium difficile Infection.
    Am J Gastroenterol. 2017;112:805.
    >> Share

    April 2017
  93. WANG YF, Chen YT, Luo JC, Chen TJ, et al
    Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
    Am J Gastroenterol. 2017 Apr 11. doi: 10.1038/ajg.2017.
    >> Share

  94. UEHARA A, Okumura T
    Esophageal Anisakiasis Mimicking Gastroesophageal Reflux Disease.
    Am J Gastroenterol. 2017;112:532.
    >> Share

  95. SUGIYAMA T, Oda H
    Proton Pump Inhibitors and Hip Strength.
    Am J Gastroenterol. 2017;112:651-652.
    >> Share

  96. ZHU T, Yuan LQ
    Complex Relationship Between Proton Pump Inhibitor Use and Bone Health.
    Am J Gastroenterol. 2017;112:651.
    >> Share

    March 2017
  97. ZIRK-SADOWSKI J, Masoli JA, Strain WD, Delgado J, et al
    Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients.
    Am J Gastroenterol. 2017;112:520-523.
    >> Share

    February 2017
  98. XING X, Cui Y, Wang J, Wang J, et al
    Endoscopic Hemostasis for a Massively Bleeding Large Gastric Ulcer with Deep Base.
    Am J Gastroenterol. 2017;112:210.
    >> Share

    January 2017
  99. JENSEN DM, Eklund S, Persson T, Ahlbom H, et al
    Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial.
    Am J Gastroenterol. 2017 Jan 17. doi: 10.1038/ajg.2016.
    >> Share

  100. CHEY WD, Leontiadis GI, Howden CW, Moss SF, et al
    ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    >> Share

  101. VAEZI MF, Choksi Y
    Mucosal Impedance: A New Way To Diagnose Reflux Disease and How It Could Change Your Practice.
    Am J Gastroenterol. 2017;112:4-7.
    >> Share

    December 2016
  102. HSU PI, Wu DC, Tsay FW, Cheng JS, et al
    Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
    Am J Gastroenterol. 2016 Dec 6. doi: 10.1038/ajg.2016.
    >> Share

    November 2016
  103. TARGOWNIK LE, Goertzen AL, Luo Y, Leslie WD, et al
    Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.
    Am J Gastroenterol. 2016 Nov 15. doi: 10.1038/ajg.2016.
    >> Share

    October 2016
  104. PETERSON K, Bjorkman DJ
    Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach?
    Am J Gastroenterol. 2016;111:1399-1401.
    >> Share

    September 2016
  105. CHEN Q, Zhang W, Fu Q, Liang X, et al
    Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
    Am J Gastroenterol. 2016 Sep 27. doi: 10.1038/ajg.2016.
    >> Share

    July 2016
  106. ZHANG H, Wang Z, Cao D
    False Aneurysm of the Common Hepatic Artery Ruptured Into the Duodenum.
    Am J Gastroenterol. 2016;111:922.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016